Bracing new numbers emerge on risks of radiative head imaging in pediatrics

If 1,265 children benefit from repeated head CT scans while suffering no harms from the cumulative exposure to ionizing radiation, is the one child out of that cohort who gets a radiation-associated brain tumor—that is, child No. 1,266—to be considered acceptable collateral damage in the wider war on childhood illness and injury? 

The hypothetical is probably best left to trusted medical ethicists. 

In any case, a large new study shows this very conundrum may be in play when youngsters’ heads are repeatedly scanned with radiative imaging modalities over time. 

“By age 21 years, the excess cumulative incidence associated with an [ionizing radiation] exposure comparable to one head CT was 7.9 per 10,000 children, corresponding to approximately one excess brain tumor per 1,266 head CTs,” the researchers behind the new findings write. “Associations were robust in sensitivity analyses.”

The team’s primary conclusion from this finding and their others: Radiative head imaging in children and adolescents is, as suggested in prior research, associated indeed with a dose-related increase in brain tumor risk. 

The authors of the present work urge pediatric imagers to not only minimize radiation doses—that’s a given—but also to apply “careful clinical justification” when pediatric imaging using ionizing radiation is indicated, especially for suspected brain conditions.

The Journal of the American Medical Association published the work online Nov. 19. 

Risk in focus 

For the study, Diana Miglioretti, PhD, of UC-Davis and colleagues at numerous institutions analyzed the medical histories of more than 3.7 million children in the U.S. and Canada who were born between 1996 and 2016 and had no cancer when they were 2 years old. 

Zeroing in on cumulative radiation doses to the brain from all head imaging that used ionizing radiation, they found more than 1,500 of the several million went on to develop brain tumors by the time they turned 21.

Close to two-thirds of these tumors appeared by age 10, and some 82.5% were classified as aggressive. 

Miglioretti and colleagues further found tumor risk rose with higher cumulative radiation dose to the brain. 

They also uncovered a statistically significant dose-response association overall as well as a stronger association for tumors with aggressive histologies.

Among their key other findings and observations:

  • The observed associations occurred at dose levels corresponding to commonly performed imaging examinations. For example, the researchers found head CT—the most common CT exam performed in children—had an average radiation dose to the brain of 66 milligrays and was associated with a 1.8-fold increased risk of brain tumor. 
     
  • Pediatric imaging using ionizing radiation can be lifesaving; however, the findings reinforce the importance of clinical justification and dose optimization. “Despite substantial evidence supporting selective use of head CT in children, potentially avoidable imaging persists,” Miglioretti and co-authors remark, noting that pediatric CT use has increased markedly over the past few decades. 
     
  • CT doses also vary substantially, with opportunities for reduction through protocol optimization. For minor head trauma, validated PECARN (Pediatric Emergency Care Applied Research Network) prediction rules can identify children at very low risk of clinically important traumatic brain injury who may safely avoid CT, the authors point out. They cite prior studies showing both high sensitivity and substantial potential reductions in CT use. 

A balance must be struck  

Clinicians should balance the immediate concern of missing an intracranial injury on head CT against a small, delayed cancer risk, Miglioretti and team advise. 

They underscore the literature showing brain tumors are the second most common childhood cancers—only leukemia strikes more—and the leading cause of cancer death among children and adolescents.

“This study adds to the growing evidence that pediatric medical imaging with ionizing radiation is associated with increased cancer risk,” Miglioretti et al write. 

“Although such imaging can enable rapid diagnosis and timely clinical management, children are especially susceptible to radiation-induced cancer because of higher rates of cell division and longer remaining life expectancy.” 

More: 

These findings reinforce the importance of ensuring that pediatric imaging examinations that use ionizing radiation are ordered only when clinically justified and performed using optimized protocols that minimize dose.

The full study is here, and UC-Davis Health has posted consumer coverage here.

Invited commentary: Hear, hear 

Commenting on the Miglioretti et al. study, senior researcher Ruggero De Maria, MD, and colleagues suggest the work helps clarify the impact of radiative pediatric imaging at the population level. 

“Longer follow-up beyond age 21 years, more complete data on clinical indications and technical parameters, and integration of molecular tumor classification and germline susceptibility would refine the magnitude and distribution of risk,” De Maria and co-authors remark. 

“For clinical practice, the standard remains straightforward: Select the examination most likely to answer the clinical question, use ionizing radiation when its expected benefit justifies the exposure, and obtain the necessary diagnostic information with the lowest dose compatible with adequate image quality.”

 

Subscribe to Health Exec News

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Subscribe to Health Exec News

Subscribe to Health Exec News